Golidocitinib Combined With Selinexor for CAEBVD

Clinical trial NCT07369739 · RECRUITING

Trial details

NCT number: NCT07369739
Sponsor: Beijing Friendship Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lymphohistiocytosis EBV CAEBV

Start date: 2026-01-01
Primary completion: 2027-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.